BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 25076727)

  • 1. Echinocandins--new antifungal agents.
    Stan CD; Tuchiluş C; Stan CI
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):528-36. PubMed ID: 25076727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The echinocandins: three useful choices or three too many?
    Bal AM
    Int J Antimicrob Agents; 2010 Jan; 35(1):13-8. PubMed ID: 19942413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].
    Catalán-González M; Carlos Montejo-González J
    Rev Iberoam Micol; 2009 Mar; 26(1):23-34. PubMed ID: 19463274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Echinocandins in children].
    Leverger G; Le Guyader N
    Arch Pediatr; 2011 May; 18 Suppl 1():S33-41. PubMed ID: 21596285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echinocandin antifungal drugs in fungal infections: a comparison.
    Chen SC; Slavin MA; Sorrell TC
    Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antifungal activity of micafungin].
    Quindós G; Eraso E; Javier Carrillo-Muñoz A; Cantón E; Pemán J
    Rev Iberoam Micol; 2009 Mar; 26(1):35-41. PubMed ID: 19463275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echinocandins: The Expanding Antifungal Armamentarium.
    Aguilar-Zapata D; Petraitiene R; Petraitis V
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes.
    Song JC; Stevens DA
    Crit Rev Microbiol; 2016 Sep; 42(5):813-46. PubMed ID: 26369708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB; Rathi SA; Ratho N; Subramanian R
    J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins.
    Hinske LC; Weis F; Heyn J; Hinske P; Beiras-Fernandez A
    Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):1-7. PubMed ID: 22044354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echinocandins: production and applications.
    Emri T; Majoros L; Tóth V; Pócsi I
    Appl Microbiol Biotechnol; 2013 Apr; 97(8):3267-84. PubMed ID: 23463246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative evaluation of properties and clinical efficacy of the echinocandins.
    Kim R; Khachikian D; Reboli AC
    Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on echinocandin antifungals.
    Kauffman CA; Carver PL
    Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echinocandins in the management of invasive fungal infections, Part 2.
    Morris MI; Villmann M
    Am J Health Syst Pharm; 2006 Oct; 63(19):1813-20. PubMed ID: 16990627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of micafungin against Candida biofilms].
    Quindós G; Villar-Vidal M; Eraso E
    Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antifungal agents.
    Gupta AK; Tomas E
    Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.